# A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent

> **NCT02104986** · PHASE2 · COMPLETED · sponsor: **Centre Leon Berard** · enrollment: 117 (actual)

## Conditions studied

- Extra Cranial Non Seminomateous Malignant Germ Cell Tumour

## Interventions

- **DRUG:** Velbe-Bleomycin-Cisplatin
- **DRUG:** Vepeside-ifosfamide-Cisplatin

## Key facts

- **NCT ID:** NCT02104986
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-12
- **Primary completion:** 2021-10-14
- **Final completion:** 2021-10-14
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2022-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02104986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02104986, "A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02104986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*